Treatment with immune modulators in a child with recent-onset type 1 narcolepsy

Sleep Breath. 2021 Mar;25(1):387-389. doi: 10.1007/s11325-020-02034-z. Epub 2020 Aug 19.

Authors

Qidi Ding¹, Fulong Xiao¹, Xiaosong Dong¹, Jun Zhang², Fang Han³

Affiliations

¹ Sleep Medicine Center Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China.
² Department of Neurology, Peking University People's Hospital, Beijing, 100044, China.
³ Sleep Medicine Center Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China. hanfang1@hotmail.com.

PMID: 32813213
DOI: 10.1007/s11325-020-02034-z

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Child, Preschool
Drug Administration Schedule
Humans
Immunomodulating Agents / administration & dosage
Immunomodulating Agents / therapeutic use*
Male
Methylprednisolone / administration & dosage
Methylprednisolone / therapeutic use*
Narcolepsy / drug therapy*
Polysomnography
Prednisolone / administration & dosage
Prednisolone / therapeutic use*

Substances

Immunomodulating Agents
Prednisolone
Methylprednisolone

Supplementary concepts

Narcolepsy 1

Grants and funding

81570083/NSFC